Intracellular protein dysregulation underlies many cancers, neurodegenerative disorders, and infectious diseases, yet a substantial fraction of the human proteome remains inaccessible to conventional small-molecule drugs or extracellular antibodies. Genetically encoded intracellular binders, including nanobodies, DARPi...
N. Barykina, V. Verkhusha· Nature Biomedical Engineerin...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.